Skip to main content

Islam Saqib's Form 4 filing

SpringWorks Therapeutics, Inc.SWTX · filed Feb 24, 2025

Accession no.
0001104659-25-016617
Filed
Feb 24, 2025
Trade date
Feb 20, 2025
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions. Open-market sales total $1.77M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Islam SaqibCIK 0001575408Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 20, 2025Common StockSSaleDisposed−24,260$60.10F2−$1,458,0261,039,693Direct
Feb 20, 2025Common StockSSaleDisposed−5,068$61.24F3−$310,364.321,034,625Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.90 to $60.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.93 to $61.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)